Immunotherapy for nasopharyngeal carcinoma: Current status and prospects (Review)-Reference-Cited by-同舟云学术

Immunotherapy for nasopharyngeal carcinoma: Current status and prospects (Review)

Published:2023-07-05 Issue:2 Volume:63 Page:
ISSN:1019-6439
Container-title:International Journal of Oncology
language:
Short-container-title:Int J Oncol

Author:

Huang Huageng¹,Yao Yuyi¹,Deng Xinyi²,Huang Zongyao³,Chen Yungchang³,Wang Zhao¹,Hong Huangming³,Huang He¹,Lin Tongyu¹

Affiliation:

1. Department of Oncology, Sun Yat‑sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong 510060, P.R. China

2. Department of Dermatology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, P.R. China

3. Department of Oncology, Senior Ward and Phase I Clinical Trial Ward, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan 610000, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference130 articles.

1. Nasopharyngeal carcinoma: An evolving paradigm;Wong;Nat Rev Clin Oncol,2021

2. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

3. Novel therapies boosting T cell immunity in epstein barr virus-associated nasopharyngeal carcinoma;Renaud;Int J Mol Sci,2020

4. The National Cancer Data Base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma;Marks;Cancer,1998

5. A new prognostic histopathologic classification of nasopharyngeal carcinoma;Wang;Chin J Cancer,2016

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Food and Drug Administration (FDA) Approvals of Biological Drugs in 2023;Biomedicines;2024-09-02

2. Letter to the Editor, “Immunochemotherapy alone or immunochemotherapy plus subsequent locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma”;Oral Oncology;2024-09

3. Single-cell resolution profiling of the immune microenvironment in primary and metastatic nasopharyngeal carcinoma;Journal of Cancer Research and Clinical Oncology;2024-08-19

4. Main chemical constituents and mechanism of anti‐tumor action of Solanum nigrum L;Cancer Medicine;2024-08

5. EBV-positive glycoproteins associated with nasopharyngeal carcinoma;Pathology - Research and Practice;2024-08